Specificity of bile salt sulfatase activity in man, mouse and rat intestinal microflora

doi:10.1016/0022-4731(84)90404-7

Journal of Steroid Biochemistry

Volume 20, Issue 4, Part 1, April 1984, Pages 907-912

https://doi.org/10.1016/0022-4731(84)90404-7 Get rights and content

Abstract

Desulfation of bile acid 3-, 7- and 12-monosulfates was studied in incubates of fecal flora of man, rat and mouse. In anaerobic incubates, the 3α-sulfates of the 5β-bile acids chenodeoxycholic acid and cholic acid, as well as the 3α-sulfate of the 5α-bile acid allochenodeoxycholic acid, were desulfated and further metabolized with the formation of a variety of metabolites. Desulfation yields were low in aerobically incubated samples, and aerobic subcultures were always negative. The 7- or 12-monosulfate esters of chenodeoxycholic acid and cholic acid were not hydrolyzed, neither anaerobically nor aerobically. High numbers (10⁷ per 10⁹ total count) of bile salt 3-sulfatase producing bacteria were present in rat cecal contents. No desulfating bacteria were detected in the proximal or medium small intestine of the rat, whereas low numbers were found in 2 out of 5 samples from the distal small intestine. These results reflect the predominantly anaerobic character of the bile salt sulfatase producing microflora in the intestine and suggest that the intestinal microflora of man, rat and mouse do not possess bile salt 7- or 12-sulfatase activity.

References (24)

A.E. Cowen et al.
Metabolism of lithocholate in healthy man. II. Enterohepatic circulation
Gastroenterohgy
(1975)
M.I. Kelsey et al.
Characterization of microbial metabolites of sulfolithocholic acid by high-performance liquid chromatography
J. steroid Biochem.
(1981)
T.S. Low-Beer et al.
Effects of sulfation of taurolithocholic and glycolithocholic acids on their intestinal transport
Gastroenterology
(1969)
M.A. Islam et al.
Isolation and quantitation of sulfated and unsulfated steroids in human feces
Analyt. Biochem.
(1981)
H. Eyssen et al.
Sex-linked differences in bile acid metabolism of germfree rats
Life Sci.
(1977)
A.E. Cowen et al.
Metabolism of lithocholate in health man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates
Gastroenterology
(1975)
H. Eriksson et al.
Occurrence of sulfated 5α-cholanoates in rat bile
J. Lipid Res.
(1978)
B. Almé et al.
Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry
J. Lipid Res.
(1977)
G. Parmentier et al.
Synthesis of the specific monosulfates ofcholic acid
Steroids
(1975)
G. Parmentier et al.
Synthesis and characteristics of the specific monosulfates of chenodeoxycholate, deoxycholate and their taurine or glycine conjugates
Steroids
(1977)

W.H. Elliott et al.

Gas chromatography of new bile acids and their derivatives

J. Chromatog.

(1969)

R.B. Kirkpatrick et al.

Identification of the 3-sulfate isomer as the major product of enzymatic sulfation of chenodeoxycholate conjugates

J. biol. Chem.

(1980)

Cited by (22)

Gut microbiota-derived metabolites in host physiology
2022, Metabolomics Perspectives: From Theory to Practical Application
Gut microbiota is a master regulator of host physiology. Intestinal microbes produce numerous metabolites through primary and secondary metabolic pathways, and many of which are dependent on host diet. The effects exerted by these microbial-derived metabolites represent the combined output of host-microbes interactions, which influence host energy metabolism, development and function of the immune system, maintenance of mucosal integrity, as well as intestinal microbiota community dynamics. In this chapter, we provide an overview of the methodologies used in metabolomic studies to dissect and understand host-microbiota interactions. Furthermore, we discuss the current knowledge on specific microbial-derived metabolites, notably secondary bile acids, short chain fatty acids, and tryptophan metabolites and their role in affecting host health.
Gut microbiome and bile acids in obesity-related diseases
2021, Best Practice and Research: Clinical Endocrinology and Metabolism
Citation Excerpt :
For example, sulfated BAs need to be de-sulfated before further bacterial transformations can take place [15,16]. This reaction is known to occur in the large bowel [16]. The species involved are not well-known in humans, while species from the genus Clostridium are shown to express this activity in rats [17].
Dysbiosis has been implemented in the etiologies of obesity-related chronic diseases such as type 2 diabetes, NAFLD and cardiovascular diseases. Bile acids, a class of amphipathic steroids produced in the liver and extensively modified by the microbiome, are increasingly recognized as actors in onset and progression of these diseases. Indeed, human obesity is associated with altered bile acid metabolism. Bile acids facilitate intestinal fat absorption but also exert hormone-like functions through activation of nuclear and membrane-bound receptors and thereby modulate glucose, lipid and energy metabolism, intestinal integrity and immunity. Bile acid-signaling pathways have thus been identified as potential pharmacological targets for obesity-related diseases. Interfering with microbiome composition may also be considered, as liver- and microbiome-derived bile acid species have different signaling functions. This review summarizes recent developments in this rapidly expanding field of research and addresses potential clinical prospects of interference with bile acid signaling pathways in human diseases.
Biogeography of microbial bile acid transformations along the murine gut
2020, Journal of Lipid Research
Bile acids, which are synthesized from cholesterol by the liver, are chemically transformed along the intestinal tract by the gut microbiota, and the products of these transformations signal through host receptors, affecting overall host health. These transformations include bile acid deconjugation, oxidation, and 7α-dehydroxylation. An understanding of the biogeography of bile acid transformations in the gut is critical because deconjugation is a prerequisite for 7α-dehydroxylation and because most gut microorganisms harbor bile acid transformation capacity. Here, we used a coupled metabolomic and metaproteomic approach to probe in vivo activity of the gut microbial community in a gnotobiotic mouse model. Results revealed the involvement of Clostridium scindens in 7α-dehydroxylation, of the genera Muribaculum and Bacteroides in deconjugation, and of six additional organisms in oxidation (the genera Clostridium, Muribaculum, Bacteroides, Bifidobacterium, Acutalibacter, and Akkermansia). Furthermore, the bile acid profile in mice with a more complex microbiota, a dysbiosed microbiota, or no microbiota was considered. For instance, conventional mice harbor a large diversity of bile acids, but treatment with an antibiotic such as clindamycin results in the complete inhibition of 7α-dehydroxylation, underscoring the strong inhibition of organisms that are capable of carrying out this process by this compound. Finally, a comparison of the hepatic bile acid pool size as a function of microbiota revealed that a reduced microbiota affects host signaling but not necessarily bile acid synthesis. In this study, bile acid transformations were mapped to the associated active microorganisms, offering a systematic characterization of the relationship between microbiota and bile acid composition.
Bile acid preparation and comprehensive analysis by high performance liquid chromatography–high-resolution mass spectrometry
2017, Clinica Chimica Acta
Citation Excerpt :
Furthermore, due to different polarities of sulfated (and in a lower extent of glucuronidated) BAs, a different chromatographic method was needed. Deglucuronidation (without desulfation) of BAs from urine or diluted bile by E. coli β-glucuronidase is complete after 2 h, as it is also shown in the literature for steroid analysis [20–22]. Incubation with Helix pomatia β-glucuronidase yielded highest peak areas of BAs after incubation for 12 h.
Accurate analytical methods for bile acid (BA) analysis are important for clinical diagnosis in newborns, adolescents, and adults. Improvements in speed, sensitivity and simplicity enable BA profiling using high performance liquid chromatography (HPLC) together with electrospray ionization (ESI) and high-resolution mass spectrometry (HR-MS).
We present a method, validated in different species and tissues, enabling a highly sensitive quantitative determination (in a range of 0.24 pmol/sample to 1000 pmol/sample, corresponding to 0.024–100 pmol on column) of up to 36 naturally occurring BAs from as little as 10 μl of plasma or serum, 1 ml of urine, or 10 mg of dried stool. Chromatographic separation is achieved by HPLC using a C18 reversed phase column and a water/methanol gradient. After ESI, BAs are analyzed through HR-MS using orbitrap technology in full scan mode. 30 different BAs and the corresponding internal standards are separated and analyzed in a single run. Six additional BAs are evaluated in a second run using a pentafluorophenyl (PFP) stationary phase.
This method generates detailed human and rodent BA profiles in full scan mode and accurate mass with the advantage of remarkably low required sample volume.
Intestinal transport and metabolism of bile acids
2015, Journal of Lipid Research
Citation Excerpt :
Although both glycine and taurine N-acyl amidated bile acid species are extensively deconjugated during transit through the colon prior to their elimination in the feces, evidence from in vitro and in vivo studies suggest that glycine-conjugated bile acids are more susceptible to deconjugation than taurine conjugates (178, 186–188). In contrast, bile acids conjugated to sulfates are relatively resistant to intestinal bacterial metabolism (189, 190), more so for the C-7 sulfated bile acids than the C-3 conjugates (191). In addition to deconjugation, bile acids undergo additional transformations, the most significant being 7α/β-dehydroxylation, which converts primary bile acids to secondary bile acids (i.e., CA to DCA, CDCA or UDCA to LCA, and MCA to MDCA).
In addition to their classical roles as detergents to aid in the process of digestion, bile acids have been identified as important signaling molecules that function through various nuclear and G protein-coupled receptors to regulate a myriad of cellular and molecular functions across both metabolic and nonmetabolic pathways. Signaling via these pathways will vary depending on the tissue and the concentration and chemical structure of the bile acid species. Important determinants of the size and composition of the bile acid pool are their efficient enterohepatic recirculation, their host and microbial metabolism, and the homeostatic feedback mechanisms connecting hepatocytes, enterocytes, and the luminal microbiota. This review focuses on the mammalian intestine, discussing the physiology of bile acid transport, the metabolism of bile acids in the gut, and new developments in our understanding of how intestinal metabolism, particularly by the gut microbiota, affects bile acid signaling.
Microbial biotransformations of bile acids as detected by electrospray mass spectrometry
2013, Advances in Nutrition
Many current experiments investigating the effects of diet, dietary supplements, and pre- and probiotics on the intestinal environments do not take into consideration the potential for using bile salts as markers of environmental change. Intestinal bacteria in vertebrates can metabolize bile acids into a number of different structures, with deamidation, hydroxyl group oxidation, and hydroxyl group elimination. Fecal bile acids are readily available to sample and contain a considerable structural complexity that directly relates to intestinal morphology, bile acid residence time in the intestine, and the species of microbial forms in the intestinal tract. Here we offer a classification scheme that can serve as an initial guide to interpret the different bile acid patterns expressed in vertebrate feces.

View all citing articles on Scopus

^∗: S. M. Huijghebaert is Research Assistant of the Belgian National Fund for Scientific Research.

View full text

Specificity of bile salt sulfatase activity in man, mouse and rat intestinal microflora

Abstract

Gastroenterohgy

J. steroid Biochem.

Gastroenterology

Analyt. Biochem.

Life Sci.

Gastroenterology

J. Lipid Res.

J. Lipid Res.

Steroids

Steroids

J. Chromatog.

J. biol. Chem.